Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase high-performance liquid chromatography-Reference-Cited by-同舟云学术

Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase high-performance liquid chromatography

Published:1995-11 Issue:2 Volume:673 Page:306-310
ISSN:0378-4347
Container-title:Journal of Chromatography B: Biomedical Sciences and Applications
language:en
Short-container-title:Journal of Chromatography B: Biomedical Sciences and Applications

Author:

Wong Yiu-chung,Charles Bruce Gordon

Publisher

Elsevier BV

Subject

General Chemistry

Reference12 articles.

1. Lisinopril

2. Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

3. Angiotensin Converting Enzyme Inhibition in Heart, Kidney, and Serum Studied Ex Vivo after Administration of Zofenopril, Captopril, and Lisinopril

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch on fluorescence probe for the selective determination of lisinopril in pharmaceutical formulations: application to content uniformity testing;RSC Advances;2018

2. An innovative validated spectrofluorimetric method for determination of Lisinopril in presence of hydrochlorothiazide; application to content uniformity testing;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2018-01

3. Concurrent determination of Metformin and some ACE inhibitors: Its application to Pharmacokinetics;Arabian Journal of Chemistry;2017-05

4. Determination of lisinopril using β-cyclodextrin/graphene oxide-SO3H modified glassy carbon electrode;Journal of Applied Electrochemistry;2014-04-17

5. Simultaneous determination of metformin, captopril, lisinopril, and enalapril by RP-HPLC: its applications in dosage formulations and in human serum;Medicinal Chemistry Research;2013-03-10